Matrix metalloproteinase-7 and premalignant host responses in Helicobacter pylori-infected mice

Seth R Ogden1, Jennifer M Noto, Shannon S Allen

  • 1Department of Medicine, Vanderbilt University, Nashville, Tennessee 37232-2279, USA.

Cancer Research
|January 6, 2010
PubMed

Insights

Matrix metalloproteinase-7 (MMP-7) deficiency exacerbates Helicobacter pylori-induced gastritis in mice. MMP-7 appears to protect the gastric mucosa, potentially reducing cancer risk by mitigating inflammation and cellular turnover.

Area of Science:

  • Gastroenterology
  • Immunology
  • Oncology

Background:

  • Helicobacter pylori infection is a primary cause of gastric adenocarcinoma.
  • Matrix metalloproteinase-7 (MMP-7) is implicated in tumorigenesis and modulated by H. pylori.
  • MMP-7 influences the gastric microbial environment and epithelial cell behavior.

Purpose of the Study:

  • To investigate the role of MMP-7 in H. pylori-induced gastritis using a murine model.
  • To determine if MMP-7 deficiency impacts gastric inflammation, cellular turnover, and bacterial eradication.

Main Methods:

  • Utilized a transgenic murine model deficient in MMP-7 (mmp-7-/-).
  • Infected mice with H. pylori to induce gastritis.
  • Assessed gastric inflammation, Th1/Th17 pathways, epithelial cell turnover, proliferation, and apoptosis.

Main Results:

  • MMP-7 deficient mice exhibited increased gastric inflammation upon H. pylori infection.
  • Enhanced gastritis was associated with Th1 and Th17 immune responses.
  • Accelerated epithelial cell turnover was observed in MMP-7 deficient mice.
  • Increased inflammation, proliferation, and apoptosis were not dependent on MMP-7 for bacterial clearance.

Conclusions:

  • H. pylori-induced MMP-7 expression may protect the gastric mucosa.
  • MMP-7 deficiency exacerbates gastritis and associated pathophysiological processes.
  • These findings suggest MMP-7 plays a protective role against H. pylori-driven carcinogenesis.

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.